AU2002257333A1 - Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms - Google Patents

Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Info

Publication number
AU2002257333A1
AU2002257333A1 AU2002257333A AU2002257333A AU2002257333A1 AU 2002257333 A1 AU2002257333 A1 AU 2002257333A1 AU 2002257333 A AU2002257333 A AU 2002257333A AU 2002257333 A AU2002257333 A AU 2002257333A AU 2002257333 A1 AU2002257333 A1 AU 2002257333A1
Authority
AU
Australia
Prior art keywords
isoforms
neurodegenerative diseases
trkc
trkb
novel treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002257333A
Inventor
Linda L. Bambrick
Susan G. Dorsey
Tami J. Kingsbury
Bruce K. Krueger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
Bambrick Linda
Dorsey Susan
Krueger Bruce
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/005151 external-priority patent/WO2002067858A2/en
Application filed by Bambrick Linda, Dorsey Susan, Krueger Bruce, University of Maryland at Baltimore filed Critical Bambrick Linda
Publication of AU2002257333A1 publication Critical patent/AU2002257333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
AU2002257333A 2002-02-22 2002-05-28 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms Abandoned AU2002257333A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002306556 2002-02-22
PCT/US2002/005151 WO2002067858A2 (en) 2001-02-22 2002-02-22 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
PCT/US2002/016807 WO2003071872A1 (en) 2002-02-22 2002-05-28 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Publications (1)

Publication Number Publication Date
AU2002257333A1 true AU2002257333A1 (en) 2003-09-09

Family

ID=27765150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002257333A Abandoned AU2002257333A1 (en) 2002-02-22 2002-05-28 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Country Status (2)

Country Link
AU (1) AU2002257333A1 (en)
WO (1) WO2003071872A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100402655C (en) * 2005-03-17 2008-07-16 中山大学中山医学院科技开发中心 Method for constructing human neurenergen-3 receptor gene recombination adenovirus
GB2491106A (en) * 2011-05-18 2012-11-28 Univ Basel Antibodies against tropomyosin-related kinase B receptors
US10066229B2 (en) * 2015-07-28 2018-09-04 Otonomy, Inc. Treatment using truncated Trk B and Trk C antagonists
GB201711809D0 (en) * 2017-07-21 2017-09-06 Governors Of The Univ Of Alberta Antisense oligonucleotide

Also Published As

Publication number Publication date
WO2003071872A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
EP1765388B8 (en) Combination therapy for preventing or treating alzheimer's disease, and kit therefor
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003221745A1 (en) rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2003268531A1 (en) Materials and methods for treatment of allergic diseases
EP1753445A4 (en) Treatment of ocular diseases and disorders using lantibiotic compositions
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
IL165397A0 (en) Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
EP1499309A4 (en) Prevention and treatment of functional somatic disorders, including stress-related disorders
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
AU2003904328A0 (en) Diagnosis and treatment of neurodegenerative disorders
AU2002241343A1 (en) Decoy compositions for treating and preventing brain diseases and disorders
AU2003209150A1 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2003278559A1 (en) Herbal medicine containing cyclodextrins for the treatment of ear disorders
AU2003217971A1 (en) Gas-plasma treatment of implants
AU2003259833A1 (en) Methods of treating neurodegenerative diseases
AU2002257333A1 (en) Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
AU2002306556A1 (en) Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003291730A1 (en) Methods and compositions for treating neurodegenerative diseases
AU2003902586A0 (en) Treatment of burns
AU2003903363A0 (en) Methods and compositions for treating disorders of the extracellular matrix
AU2003254447A1 (en) Treatment of proliferative disorders
AU2003297570A1 (en) Treatment of skin diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase